×
S&P 500   3,818.83 (-0.07%)
DOW   31,029.31 (+0.27%)
QQQ   283.86 (+0.11%)
AAPL   139.10 (+1.21%)
MSFT   260.00 (+1.37%)
META   163.83 (+1.96%)
GOOGL   2,233.00 (-0.32%)
AMZN   108.82 (+1.32%)
TSLA   685.35 (-1.81%)
NVDA   155.40 (-2.77%)
NIO   21.87 (-2.19%)
BABA   116.16 (-0.51%)
AMD   77.99 (-3.45%)
MU   56.05 (-3.13%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.74 (-0.19%)
AMC   13.63 (+1.87%)
PFE   50.94 (+0.55%)
PYPL   71.54 (-0.39%)
NFLX   178.50 (-0.61%)
S&P 500   3,818.83 (-0.07%)
DOW   31,029.31 (+0.27%)
QQQ   283.86 (+0.11%)
AAPL   139.10 (+1.21%)
MSFT   260.00 (+1.37%)
META   163.83 (+1.96%)
GOOGL   2,233.00 (-0.32%)
AMZN   108.82 (+1.32%)
TSLA   685.35 (-1.81%)
NVDA   155.40 (-2.77%)
NIO   21.87 (-2.19%)
BABA   116.16 (-0.51%)
AMD   77.99 (-3.45%)
MU   56.05 (-3.13%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.74 (-0.19%)
AMC   13.63 (+1.87%)
PFE   50.94 (+0.55%)
PYPL   71.54 (-0.39%)
NFLX   178.50 (-0.61%)
S&P 500   3,818.83 (-0.07%)
DOW   31,029.31 (+0.27%)
QQQ   283.86 (+0.11%)
AAPL   139.10 (+1.21%)
MSFT   260.00 (+1.37%)
META   163.83 (+1.96%)
GOOGL   2,233.00 (-0.32%)
AMZN   108.82 (+1.32%)
TSLA   685.35 (-1.81%)
NVDA   155.40 (-2.77%)
NIO   21.87 (-2.19%)
BABA   116.16 (-0.51%)
AMD   77.99 (-3.45%)
MU   56.05 (-3.13%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.74 (-0.19%)
AMC   13.63 (+1.87%)
PFE   50.94 (+0.55%)
PYPL   71.54 (-0.39%)
NFLX   178.50 (-0.61%)
S&P 500   3,818.83 (-0.07%)
DOW   31,029.31 (+0.27%)
QQQ   283.86 (+0.11%)
AAPL   139.10 (+1.21%)
MSFT   260.00 (+1.37%)
META   163.83 (+1.96%)
GOOGL   2,233.00 (-0.32%)
AMZN   108.82 (+1.32%)
TSLA   685.35 (-1.81%)
NVDA   155.40 (-2.77%)
NIO   21.87 (-2.19%)
BABA   116.16 (-0.51%)
AMD   77.99 (-3.45%)
MU   56.05 (-3.13%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.74 (-0.19%)
AMC   13.63 (+1.87%)
PFE   50.94 (+0.55%)
PYPL   71.54 (-0.39%)
NFLX   178.50 (-0.61%)

Allstate: A Safe Stock During Volatile Times, Which Will Benefit From Rising Rates

Thursday, June 16, 2022 | Parth Pala
Allstate: A Safe Stock During Volatile Times, Which Will Benefit From Rising Rates

Allstate (NYSE:ALL) is an American Insurance Company that provides a broad range of financial products, including auto, marine and home insurance. In addition, they also offer wealth planning services and financial products that mainly target retirement.

Investment Thesis

Allstate’s stock looks quite attractive with its current valuation and the broader economic conditions. Allstate is in a market that is very competitive, with the high barriers to entry, which makes it an attractive choice for a defensive stock. The case for investing in the stock further improves as return on investments increase due to higher interest rates. Finally, Allstate has also continued to strengthen its business through synergies gained from various acquisitions, thereby ensuring it remains competitive for the future.

An overview of Allstate’s business

Allstate’s primary business is the insurance sector. It competes with other insurance providers such as State Farm and Allstate. It is one of the market's more expensive insurance providers, with both its home and auto segments charging a rate that is higher than their competitors

Allstate's is able to charge the prices due to a higher level of product satisfaction, which stems from Allstate’s personalized services that it provides customers, services such as roadside assistance etc. As a result, Allstate has carved out a niche for itself within the insurance market, where product differentiation remains the most significant factor for competition. Despite all these factors, Allstate retains a healthy 10-11% market share.

Financial Outlook and Valuation

Allstate is likely to benefit due to interest rates rising, which should help offset some of the effects of higher payouts. COVID previously helped the company’s margins as lower payouts meant profitability improved in 2021. However, as things normalize, proceed payments have normalized as well with combined ratio rising to 98.9%, up 14.9% from the previous year. The increase has affected margins, which came in lower than the previous year during the early part of the year.


The auto-insurance sector is likely to grow around 3% for the next 4-5 years, and the non-life insurance division sector is expected to grow to around 6% for the year. Allstate is projected to bring in revenue of $48-49 billion for the year that could rise slightly to $50-51 billion as premium collection increases in the latter quarters. Otherwise, revenue would be slightly down from the $50 billion in 2021. Meanwhile, operating margins are expected to come in at 10%, and net profit margins might come in at around 7%. If net profit margins increase to 8-9% due to an increase in return on investment on premiums, the stock may rise to $128-$130 per share.

Allstate currently trades at a relatively moderate valuation with a forward price-to-earnings (PE) of 10x and a dividend yield of 2.8%. And according to the dividend discount model, Allstate’s stock is currently valued at $121 per stock, which would point to the stock being fairly valued. Moreover, should dividends increase during the latter part of the year, the stock could also rise to $128-$130 per share, which would provide a reasonable rate of return for a defensive stock.

Risks to general insurance

Large payments and adverse events remain risks that may affect insurance providers.  Usually, losses from these proceeds are capped as a result of re-insurance, but remain a risk for the stock. Furthermore, a slowdown in the economy and rising rates could affect insurance-related goods such as home and automobile demand, which would, in turn would affect demand for insurance products.

Should Allstate be a part of your portfolio?

The company remains a relatively safe option, and the operations are likely to remain steady even during a recession. Currently, the dividend yield remains attractive, and the outlook is also reasonable. Unless there is an unprecedented adverse event, insurance companies tend to have blue-chip-like qualities that allow them to overcome volatile markets without any long-term damage. But, on the other hand, the stock is unlikely to outperform the broader market since the insurance industry tends to move slowly. Consider the stock if you would like a relatively-safe blue-chip stock as a part of a defensive portfolio during these unique times.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Allstate (ALL)
3.5719 of 5 stars
$125.42-0.2%2.71%10.50Moderate Buy$145.75
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:


Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastHow to Profit In The Bear Market

Today, Kate is joined by a repeat guest, Rob Isbitts of Sungarden Investment Publishing. Rob specializes in ETF portfolios designed to deliver returns in any kind of market condition, including the current bear. In this conversation, Rob gives specific ideas for handling various allocations in your portfolio, and discusses how to approach inverse ETFs.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.